Zhuhai Beihai Biotech Co., Ltd. drugs

1 result
  • beizray

    (Docetaxel)
    Zhuhai Beihai Biotech Co., Ltd.
    BEIZRAY, in combination with cisplatin and fluorouracil, is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).